Search Within

Lilian M Reich

  1. "Cell Biology Program Faculty"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
Groups
  1. Cell Biology Program Faculty (15)
  2. Department of Medicine (15)
  3. Hematologic Malignancies, Division of (15)
  4. Sloan Kettering Institute Faculty (15)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  6. Breast Medicine Service (12)

More Groups

People
  1. Malcolm Moore (15)
  2. Larry Norton (12)
  3. Jeffrey Schneider (11)
  4. Fred Shapiro (10)
  5. John Crown (9)
  6. David Fennelly (8)

More People

Years
  1. 1997 (1)
  2. 1995 (3)
  3. 1994 (7)
  4. 1993 (3)
  5. 1992 (1)
Publications
  1. Blood (8)
  2. Bone Marrow Transplantation (1)
  3. Cancer (1)
  4. Clinical Cancer Research (1)
  5. Gynecologic Oncology (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (1)
  4. Elsevier Inc. (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells
    Journal Article

    Shapiro, F.; Yao, T. J.; Moskowitz, C.; Reich, L.; Wuest, D. L.; Heimfeld, S.; McNiece, I. K.; Gabrilove, J.; Nimer, S.; Moore, M. A. S.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • The proliferative potential of peripheral blood CD34(+) cells inversely correlates with prior therapy
    Meeting Abstract

    Shapiro, F.; Yao, T. J.; Ouerijero, M.; Moskowitz, C.; Reich, L.; Wuest, D. L.; Heimfeld, S.; McNiece, I. K.; Gabrilove, J.; Nimer, S.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
    Journal Article

    Fennelly, D.; Schneider, J.; Spriggs, D.; Bengala, C.; Hakes, T.; Reich, L.; Barakat, R.; Curtin, J.; Moore, M. A. S.; Hoskins, W.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Taxol in combination with cyclophosphamide and GCSF, a novel peripheral blood progenitor cell mobilizing regimen
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Hakes, T.; Spriggs, D.; Reich, L.; Yao, T. J.; Shapiro, F.; Norton, L.; Moore, M. A. S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • The influence of prior chemotherapy on the ability of peripheral blood derived CD34(+) cells mobilized by stem cell factor (SCF) plus granulocyte colony stimulating factor (G-CSF) to generate progenitors ex-vivo
    Meeting Abstract

    Shapiro, F.; Moskowitz, C.; Reich, L.; McNiece, I.; Heimfeld, S.; Nimer, S.; Gabrilove, J.; Moore, M. A. S.
    Blood (1994)

    Fulltext@MSK | Save
  • Peripheral blood progenitor cell (PBP) mobilization using Taxol (T) in combination with cyclophosphamide (C) and GCSF; Quantitation and correlation of CD34+ cell count, colony-forming-unit granulocyte-macrophage (CFU-GM), and mononuclear cell (MNC) count
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Reich, L.; Norton, L.; Spriggs, D.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Comparative efficacy of bone marrow engraftment following high-dose (HD) carboplatin (CBDCA) plus cyclophosphamide versus high-dose CBDCA/Taxol (TXL), when rescued with TXL cyclophosphamide (CPA) and GCSF mobilized peripheral blood progenitor cells (PBP)
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Schneider, J.; Spriggs, D.; Bengala, C.; McKenzie, M.; Reich, L.; Norton, L.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients
    Journal Article

    Schneider, J. G.; Crown, J. P.; Wasserheit, C.; Kritz, A.; Wong, G.; Reich, L.; Norton, L.; Moore, M. A. S.
    Bone Marrow Transplantation (1994)

    Fulltext@MSK | Save